Study of Urinary Impact of Spinal Dysraphism in the Pediatric Population
NCT ID: NCT07258654
Last Updated: 2025-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
210 participants
OBSERVATIONAL
2026-02-01
2026-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Uronephrological Complications Risk Factors in Spinal Dysraphism
NCT05718440
Urinary Artificial Sphincter in Children
NCT05858840
Fetal Endoscopic Surgery for Spina Bifida
NCT03315637
Bladder Neck Surgery in Children With Neurogenic Bladder
NCT05861011
Assessment and Follow-up of Surgical Treatment of Hemivertebra in Children
NCT03772119
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dyspraphism
description of the impact
Study of urinary and fecal impact of closed and dysraphism in the pediatric population
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
description of the impact
Study of urinary and fecal impact of closed and dysraphism in the pediatric population
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Angers
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Louise RENOULT
Role: STUDY_CHAIR
University Hospital, Angers
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
49RC25_0272
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.